TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized With RSV Illness
Brief Summary: The primary objective of this study is to describe the effect of a single dose of medication compared to placebo in the upper respiratory tract in previously healthy children less than or equal to 12 months of age who are hospitalized with lower respiratory tract illness.


Options:
A: Arm Label: RSVpreF vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSVpreF | Arm Label: Placebo dose; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: RSVpreF; Assigned to Arm(s): RSVpreF vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo dose
B: Arm Label: MEDI8897; Type: EXPERIMENTAL; Interventions: Drug: MEDI8897 | Arm Label: Palivizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palivizumab | Intervention Type: DRUG; Name: MEDI8897; Assigned to Arm(s): MEDI8897 | Intervention Type: DRUG; Name: Palivizumab; Assigned to Arm(s): Palivizumab
C: Arm Label: Palivizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palivizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Palivizumab; Assigned to Arm(s): Palivizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Motavizumab 30 mg/kg; Type: EXPERIMENTAL; Interventions: Biological: Motavizumab | Arm Label: Motavizumab 100 mg/kg; Type: EXPERIMENTAL; Interventions: Biological: Motavizumab | Intervention Type: BIOLOGICAL; Name: Motavizumab; Assigned to Arm(s): Motavizumab 100 mg/kg, Motavizumab 30 mg/kg | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endovascular Versus Transabdominal Treatment of the Abdominal Aortic Aneurysm: the Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial
Brief Summary: The purpose of this trial is to assess whether the new endovascular repair technique of the abdominal aortic aneurysm (AAA) is an adequate substitute of the conventional AAA repair.


Options:
A: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR
B: Arm Label: Surveillance; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Early Endovascular Repair; Type: EXPERIMENTAL; Interventions: Device: AneuRx AAA stent graft / Talent AAA stent graft | Intervention Type: DEVICE; Name: AneuRx AAA stent graft / Talent AAA stent graft; Assigned to Arm(s): Early Endovascular Repair
C: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance
D: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endovascular Versus Transabdominal Treatment of the Abdominal Aortic Aneurysm: the Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial
Brief Summary: The purpose of this trial is to assess whether the new endovascular repair technique of the abdominal aortic aneurysm (AAA) is an adequate substitute of the conventional AAA repair.


Options:
A: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open repair | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular repair (with endograft) | Intervention Type: PROCEDURE; Name: Endovascular repair (with endograft); Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Open repair; Assigned to Arm(s): 1
C: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1
D: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endovascular Versus Transabdominal Treatment of the Abdominal Aortic Aneurysm: the Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial
Brief Summary: The purpose of this trial is to assess whether the new endovascular repair technique of the abdominal aortic aneurysm (AAA) is an adequate substitute of the conventional AAA repair.


Options:
A: Arm Label: 1; Type: OTHER; Interventions: Procedure: Endovascular repair | Arm Label: 2; Type: OTHER; Interventions: Procedure: Endovascular repair | Intervention Type: PROCEDURE; Name: Endovascular repair; Assigned to Arm(s): 1, 2
B: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance
C: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1
D: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endovascular Versus Transabdominal Treatment of the Abdominal Aortic Aneurysm: the Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial
Brief Summary: The purpose of this trial is to assess whether the new endovascular repair technique of the abdominal aortic aneurysm (AAA) is an adequate substitute of the conventional AAA repair.


Options:
A: Arm Label: Surveillance; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Early Endovascular Repair; Type: EXPERIMENTAL; Interventions: Device: AneuRx AAA stent graft / Talent AAA stent graft | Intervention Type: DEVICE; Name: AneuRx AAA stent graft / Talent AAA stent graft; Assigned to Arm(s): Early Endovascular Repair
B: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance
C: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR
D: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled, Parallel Group, Single Blinded, Phase 1 Study That Investigates the Effects of Regular Daily Intake of Small Amounts of Dark or White Chocolate on Blood Pressure in Elderly Individuals With Mild Hypertension
Brief Summary: Regular intake of cocoa-containing foods is linked to a considerably lower cardiovascular and all-cause mortality in observational studies. Short-term intervention studies indicate that high doses of cocoa improve endothelial function and reduce blood pressure (BP), but the clinical impact of long-term intake of small dietary amounts of cocoa on BP and the underlying BP lowering mechanisms are unclear. We hypothesized that cocoa consumption lowers blood pressure by augmentation of the circulating vasodilative nitric oxide (NO) pool due to the action of the cocoa polyphenols at the vascular endothelium.

To test this hypothesis, we will conduct a randomized single-blind, parallel group study in subjects with mild essential hypertension to evaluate the effects of polyphenol-rich dark chocolate versus polyphenol-free white chocolate on blood pressure and plasma levels of cocoa phenols, circulating bioactive nitric oxide, and plasma markers of oxidative stress. After a 7 day cocoa-free run-in period, 44 subjects will be 1:1 randomized to receive over 18 weeks daily doses of either dark chocolate (6.3 g per day with a total of 30 mg of polyphenols and 30 kcal) or polyphenol free white chocolate (5.6 g per day with 30 kcal, containing similar amounts of macronutrients, electrolytes and vitamins). Subjects will be counseled to maintain an isocaloric diet and to abstain from other cocoa products during the study. Blood pressure and plasma parameters will be assessed in each subject after the run-in period and after 6, 12, and 18 weeks of treatment.


Options:
A: Arm Label: Flavanol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cocoa Flavanols | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Cocoa Flavanols; Assigned to Arm(s): Flavanol | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: dark chocolate; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Effects of dark chocolate; Assigned to Arm(s): N/A
D: Arm Label: Low- polyphenol diet; Type: OTHER; Interventions: Other: Two portions of fruit and vegetables per day (excluding berries and dark chocolate) | Arm Label: High-polyphenol diet; Type: ACTIVE_COMPARATOR; Interventions: Other: Six portions of fruit and vegetables per day (one of which must be berries) and 50g dark chocolate. | Intervention Type: OTHER; Name: Two portions of fruit and vegetables per day (excluding berries and dark chocolate); Assigned to Arm(s): Low- polyphenol diet | Intervention Type: OTHER; Name: Six portions of fruit and vegetables per day (one of which must be berries) and 50g dark chocolate.; Assigned to Arm(s): High-polyphenol diet

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contention Alone Versus Anticoagulation for Symptomatic Calf Vein Thrombosis Diagnosed by Ultrasonography
Brief Summary: CACTUS-PTS is a randomized, placebo-controlled, double-blind study which aims primarily to determine the effectiveness of a 6 week course of therapeutic-dose LMWH (nadroparine) injections vs. placebo in patients with a first symptomatic isolated distal (calf) deep-vein thrombosis (IDDVT), as measured by rate of proximal DVT and symptomatic PE at 6 weeks. Additionally, the study aims to determine if the 6 week course of treatment with therapeutic-dose LMWH (nadroparine) injections, compared to placebo, decreases the frequency of post-thrombotic syndrome (PTS) at 1 year.


Options:
A: Arm Label: I; Type: EXPERIMENTAL; Interventions: Procedure: catheter-directed venous thrombolysis | Arm Label: II; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: catheter-directed venous thrombolysis; Assigned to Arm(s): I
B: Arm Label: CDT+US group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CDT+US group | Arm Label: CDT-US group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CDT-US group | Intervention Type: PROCEDURE; Name: CDT+US group; Assigned to Arm(s): CDT+US group | Intervention Type: PROCEDURE; Name: CDT-US group; Assigned to Arm(s): CDT-US group
C: Arm Label: A-Intervention; Type: EXPERIMENTAL; Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA) | Arm Label: B-Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Recombinant tissue plasminogen activator (rt-PA); Assigned to Arm(s): A-Intervention
D: Arm Label: LMWH; Type: ACTIVE_COMPARATOR; Interventions: Drug: nadroparine calcium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: nadroparine calcium; Assigned to Arm(s): LMWH | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Trial Assessing the Efficacy and Safety of Grazax in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma
Brief Summary: The trial is performed to evaluate the efficacy and safety of specific immunotherapy with Grazax for treatment of grass pollen induced allergy.


Options:
A: Arm Label: SLIT; Type: EXPERIMENTAL; Interventions: Biological: sublingual immunotherapy | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo | Intervention Type: BIOLOGICAL; Name: sublingual immunotherapy; Assigned to Arm(s): SLIT | Intervention Type: BIOLOGICAL; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Birch pollen allergen extract; Type: EXPERIMENTAL; Interventions: Biological: Birch pollen allergen extract | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Birch pollen allergen extract; Assigned to Arm(s): Birch pollen allergen extract
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Staloral | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Staloral | Intervention Type: DRUG; Name: Staloral; Assigned to Arm(s): 1, 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Grazax | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Grazax | Intervention Type: DRUG; Name: Grazax; Assigned to Arm(s): 1, 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Trial Assessing the Efficacy and Safety of Grazax in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma
Brief Summary: The trial is performed to evaluate the efficacy and safety of specific immunotherapy with Grazax for treatment of grass pollen induced allergy.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Birch pollen allergen extract; Type: EXPERIMENTAL; Interventions: Biological: Birch pollen allergen extract | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Birch pollen allergen extract; Assigned to Arm(s): Birch pollen allergen extract
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Grazax | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Grazax; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
C: Arm Label: 300 IR; Type: EXPERIMENTAL; Interventions: Drug: 300 IR | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: 300 IR; Assigned to Arm(s): 300 IR | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Grazax | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Grazax | Intervention Type: DRUG; Name: Grazax; Assigned to Arm(s): 1, 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial of Zinc and Micronutrients in Tanzanian Children
Brief Summary: A randomized clinical trial of multiple micronutrients, zinc, zinc + micronutrients, or placebo among 2400 children born to HIV-negative Tanzanian mothers.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Drug: Vit B12 | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vit B12 | Intervention Type: DRUG; Name: Vit B12; Assigned to Arm(s): Control group, Intervention group
B: Arm Label: Vitamin B12-fortified UHT milk; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin B12 fortified UHT milk | Arm Label: Plain UHT milk; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Plain UHT milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin B12 fortified UHT milk; Assigned to Arm(s): Vitamin B12-fortified UHT milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Plain UHT milk; Assigned to Arm(s): Plain UHT milk
C: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Folic Acid | Arm Label: C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin B12 | Arm Label: D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Folic acid and vitamin B12 | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic Acid; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin B12; Assigned to Arm(s): C | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): A | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic acid and vitamin B12; Assigned to Arm(s): D
D: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins | Arm Label: Multivitamins + Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc, Drug: Multivitamins | Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Multivitamins + Zinc, Zinc | Intervention Type: DRUG; Name: Multivitamins; Assigned to Arm(s): Multivitamins, Multivitamins + Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial of Zinc and Micronutrients in Tanzanian Children
Brief Summary: A randomized clinical trial of multiple micronutrients, zinc, zinc + micronutrients, or placebo among 2400 children born to HIV-negative Tanzanian mothers.


Options:
A: Intervention Type: DRUG; Name: zinc sulphate dietary supplement; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: iron sulphate-folic acid dietary supplement; Assigned to Arm(s): N/A
B: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins | Arm Label: Multivitamins + Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc, Drug: Multivitamins | Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Multivitamins + Zinc, Zinc | Intervention Type: DRUG; Name: Multivitamins; Assigned to Arm(s): Multivitamins, Multivitamins + Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Fe, Zn, Fe+Zn, Placebo; Type: N/A; Interventions: N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Lyophilized meat | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Cereal | Intervention Type: OTHER; Name: Lyophilized meat; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Cereal; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial of Zinc and Micronutrients in Tanzanian Children
Brief Summary: A randomized clinical trial of multiple micronutrients, zinc, zinc + micronutrients, or placebo among 2400 children born to HIV-negative Tanzanian mothers.


Options:
A: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins | Arm Label: Multivitamins + Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc, Drug: Multivitamins | Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Multivitamins + Zinc, Zinc | Intervention Type: DRUG; Name: Multivitamins; Assigned to Arm(s): Multivitamins, Multivitamins + Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: zinc | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: iron + copper | Intervention Type: DIETARY_SUPPLEMENT; Name: zinc; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: iron + copper; Assigned to Arm(s): 2
C: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins - vitamins B complex, C and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Multivitamins - vitamins B complex, C and E; Assigned to Arm(s): Multivitamins | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Folic Acid | Arm Label: C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin B12 | Arm Label: D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Folic acid and vitamin B12 | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic Acid; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin B12; Assigned to Arm(s): C | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): A | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic acid and vitamin B12; Assigned to Arm(s): D

Answer: A